{"id":253339,"date":"2026-09-17T14:59:59","date_gmt":"2026-09-17T09:29:59","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=253339"},"modified":"2026-09-17T14:59:59","modified_gmt":"2026-09-17T09:29:59","slug":"diagnostics-pathology-labs-penny-stocks-india-2027","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/diagnostics-pathology-labs-penny-stocks-india-2027\/","title":{"rendered":"5 Diagnostics and Pathology Labs Penny Stocks in India Investors Are Tracking for 2027"},"content":{"rendered":"

Nephro Care India CMP Rs 92.55, market cap Rs 158.00 Cr. Sunil Healthcare trading at Rs 74.99. 5 diagnostics and pathology labs penny stocks under Rs 100 tracked for 2027.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Diagnostics and pathology labs penny stocks in India 2027 include Nephro Care India Ltd., Sunil Healthcare Ltd., Modern Diagnostic and Research Centre Ltd., Star Imaging and Path Lab Ltd. and Invicta Diagnostic Ltd., all trading under Rs 100 a share. These names give investors low-cost exposure to India’s diagnostics and pathology labs sector, though several carry thin or negative ROE and high leverage. Position sizing and independent research matter more here than with large-cap diagnostics and pathology labs stocks. This is educational content, not investment advice, and a SEBI-registered advisor should be consulted before allocating capital to any penny stock.<\/p>\n<\/div>\n

Investors tracking diagnostics and pathology labs penny stocks in India 2027 are looking at a mix of legacy names and smaller diagnostics and pathology labs players still trading under Rs 100 a share. Nephro Care India Ltd. and Sunil Healthcare Ltd. anchor this list by market cap, while smaller names such as Invicta Diagnostic Ltd. remain firmly in penny-stock territory.<\/p>\n

India’s diagnostics and pathology sector has grown with rising health awareness and preventive testing demand, but several smaller diagnostic chains and specialty clinics beyond the large national lab networks trade at low absolute prices, reflecting regional concentration and smaller scale than the branded diagnostic chains.<\/p>\n

This article lists 5 diagnostics and pathology labs stocks worth tracking for 2027, along with their current price, market capitalisation, valuation ratios and the key risks each one carries.<\/p>\n

Click Here – Get Free Investment Predictions<\/a><\/strong><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n